HAEMATOLOGICAL CANCER

Donors with CHIP are safe for allogeneic HSCT

Data from a study involving 500 related allogeneic haematopoietic stem cell transplantation (HSCT) donors demonstrate that the presence of clonal haematopoiesis of indeterminate potential (CHIP) mutations has no effect on overall survival of the recipients. A total of 92 CHIP mutations were identified in 80 donors (16%), with a median variant-allele frequency of 5.9%. The majority of patients (70) had a single detectable mutation. Patients who received stem cells harbouring CHIP mutations had an increased risk of graft-versus-host disease (HR 1.73, 95% CI 1.21–2.49; P = 0.003) and a reduced cumulative incidence of relapse and disease progression (multivariate HR 0.63, 95% CI 0.41– 0.98; P = 0.042). These findings suggest that the presence of one or more CHIP mutations should not preclude stem cell donation.

References

Original article

  1. Frick, M. et al. Role of donor clonal hematopoiesis in allogeneic hematopoietic stem-cell transplantation. J. Clin. Oncol. https://doi.org/10.1200/JCO.2018.79.2184 (2018).

    Article  PubMed  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Peter Sidaway.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Sidaway, P. Donors with CHIP are safe for allogeneic HSCT. Nat Rev Clin Oncol 16, 66 (2019). https://doi.org/10.1038/s41571-018-0140-x

Download citation